|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,609.32 |
3.45% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,490.10 |
3.00% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$58,283.62 |
2.85% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$53,894.52 |
2.63% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,824.16 |
2.53% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,631.10 |
2.33% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$47,246.31 |
2.31% |
| Waters Corporation |
WAT |
941848103 |
148 |
$47,334.84 |
2.31% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$45,675.00 |
2.23% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$45,548.16 |
2.22% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$44,794.98 |
2.19% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$44,509.80 |
2.17% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,201.30 |
2.16% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,121.99 |
2.15% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,477.96 |
2.12% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$43,197.64 |
2.11% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$42,343.18 |
2.07% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,167.84 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,095.52 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
169 |
$41,273.18 |
2.02% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$41,201.16 |
2.01% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,131.13 |
2.01% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$40,382.42 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$40,070.78 |
1.96% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,877.65 |
1.95% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$39,828.96 |
1.94% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$39,824.30 |
1.94% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$39,184.28 |
1.91% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,691.66 |
1.89% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$38,746.32 |
1.89% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,497.11 |
1.88% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$38,051.34 |
1.86% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,226.31 |
1.82% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$37,028.72 |
1.81% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$36,696.96 |
1.79% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$36,664.33 |
1.79% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$36,464.96 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,122.31 |
1.76% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$35,478.31 |
1.73% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,019.74 |
1.71% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,916.36 |
1.70% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$33,996.07 |
1.66% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$33,552.47 |
1.64% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$33,080.72 |
1.62% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,014.02 |
1.61% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,672.95 |
1.55% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$31,576.69 |
1.54% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$30,982.16 |
1.51% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$30,584.14 |
1.49% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$24,506.20 |
1.20% |
| US Dollar |
$USD |
|
2,196 |
$2,195.53 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|